ESMO Publishes New Position Paper on Supportive and Palliative Care

Food and Healthcare Press Releases Friday December 15, 2017 15:00
LUGANO, Switzerland--15 Dec--PRNewswire/InfoQuest

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757   ], calling attention to the evolving and growing gap between the needs of cancer patients and the actual provision of patient-centred care.

"New studies show that there may be a gap between what doctors think is important for patients, and what patients really need [ http://www.esmo.org/Conferences/Past-Conferences/ESMO-2017-Congress/Press-Media/Press-Releases/Patients-Feel-Psycho-social-Impact-of-Chemo-More-Acutely-Than-Physical-Side-Effects   ] . With this position paper, we wanted to call attention to the fact that, as well as anti-tumour treatment, cancer patients need physical, psychological, social, spiritual support, at every stage of the disease, from diagnosis," said main author Karin Jordan, ESMO Faculty Coordinator.

Matti Aapro, co-author, MASCC Past-president, said: "Recent studies [ http://esmo.org/Conferences/Past-Conferences/ESMO-2017-Congress/Press-Media/Press-Releases/Triggers-a-New-Tool-to-Assess-Cancer-Patients-Palliative-Needs   ] show that palliative and supportive care not only improves treatment: it contributes to better use of existing resources, avoids waste and may also reduce the cost of treatment."

Patient reported outcomes should be highly encouraged as shown to be associated with better quality of life, fewer hospitalisations and even increased survival, compared with usual care.

"We hope that this paper will contribute to develop a generalised culture and acceptance of supportive and palliative care, worldwide," said Aapro. "Basic patient needs such as pain relief are still not being widely met [ http://www.esmo.org/Policy/Global-Opioid-Policy-Initiative   ]. Education is vital to make sure that essential supportive care is accessible to all cancer patients, everywhere."

ESMO position paper content:
  • Key patient-centred care interventions and training
  • End-of-life care
  • Role of multidisciplinary teams
  • Integrating healthcare resources
  • Research and resources in supportive and palliative care
Full story:   http://bit.ly/2AiD5qG

ESMO is the leading professional organisation for medical oncology. With 17,000 members representing oncology professionals from 150 countries worldwide, ESMO is the society of reference for oncology education and information.

media@esmo.org
+41-91-973-19-07
Source: European Society for Medical Oncology (ESMO)

Latest Press Release

Israel Ministry of Health Includes INSIGHTEC#s Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services

INSIGHTEC(R), a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced today that the Neuravive focused ultrasound treatment will be a covered service for essential tremor...

The ImplantCenter Marks a New Era in the Hungarian Private Dental Service

The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education...

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or metastatic non-small cell lung cancer (NSCLC) whose disease progressed after...

PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates

PharmaMar (MCE: PHM) has announced today the signing of an exclusive licensing agreement with Seattle Genetics Inc. (SGEN: NASDAQ GS) under which Seattle Genetics receives exclusive worldwide rights to certain PharmaMar proprietary molecules for the...

After multiple failed procedures at other medical institutions, Colorado man successfully treated for Atrial Fibrillation at Texas Cardiac Arrhythmia Institute at St. David#s Medical Center

"I was thinking I was on top of the world," Wiseman said. "I was keeping myself in shape. I was taking care of myself mentally and physically. My relationship was solid." Then, during a routine medical exam while serving in the military in California,...

Related Topics